ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

6 links4 made here, not in the record6 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07037199Efficacy and Safety ofTrastuzumab RezetecanFollowed by CDK4/6Inhibitors and EndocrineTherapy inHR+/HER2-Low/Ultra-LowAdvanced Breast CancerSun Yat-Sen Memorial Hospital Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSBreast NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSPalbociclibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · partnerBackground · partnerRibociclibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · partnerBackground · partnerAbemaciclibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · partnerBackground · partnerFulvestrantMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · partnerBackground · partnerTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Palbociclib

Made here1 judgment on this link
NCT07037199gives it, found by reading the recordPalbociclibDefined by Claude Opus 5.5Nov 3, 2026, 7:57 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2TrastuzumabClaude Opus 5.5Not givenCurrent
Nov 3Palbociclibmade hereClaude Opus 5.5Background · partnerCurrent
Nov 3Ribociclibmade hereClaude Opus 5.5Background · partnerCurrent
Nov 3Abemaciclibmade hereClaude Opus 5.5Background · partnerCurrent
Nov 3Fulvestrantmade hereClaude Opus 5.5Background · partnerCurrent
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.